12 Health Care Stocks Moving In Tuesday's Pre-Market Session
GainersBiodexa Pharmaceuticals (NASDAQ:BDRX) shares increased by 67.7% to $2.13 during Tuesday's pre-market session. The market value of their outstanding shares is at $9.3 million. Durect (NASDAQ:DRR
Envoy Medical's Stability Threatened: Potential Defaults on Senior Securities May Shake Investor Confidence
Envoy Medical Q1 2024 GAAP EPS $(0.32), Sales $59.00K Miss $100.00K Estimate
Envoy Medical (NASDAQ:COCH) reported quarterly losses of $(0.32) per share. The company reported quarterly sales of $59.00 thousand which missed the analyst consensus estimate of $100.00 thousand by
Envoy Medical 1Q Rev $59,000 >COCH
Envoy Medical 1Q Rev $59,000 >COCH
Earnings Flash (COCH) ENVOY MEDICAL Reports Q1 Revenue $59,000
04:06 PM EDT, 05/15/2024 (MT Newswires) -- Earnings Flash (COCH) ENVOY MEDICAL Reports Q1 Revenue $59,000
10-Q: Quarterly report
How Envoy Medical Is Disrupting the Hearing Loss Industry
Why Ultragenyx Pharmaceutical Shares Are Trading Lower By Around 9%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Shares of Ultragenyx Pharmaceutical Inc. (NASDAQ:RARE) fell sharply during Monday's session after the company revealed new data from the Phase 1/2 study of GTX-102 for Angelman syndrome, a genetic d
Marinus Pharmaceuticals, Cartesian Therapeutics, Adial Pharmaceuticals Among Healthcare Movers
12 Health Care Stocks Moving In Monday's Pre-Market Session
GainersSoligenix (NASDAQ:SNGX) stock increased by 95.1% to $0.75 during Monday's pre-market session. The company's market cap stands at $7.9 million. Longeveron (NASDAQ:LGVN) shares increased by 51.47
Why Byrna Technologies Shares Are Trading Higher By Around 7%? Here Are Other Stocks Moving In Friday's Mid-Day Session
Shares of Byrna Technologies Inc. (NASDAQ:BYRN) rose sharply during Friday's session after the company reported better-than-expected first-quarter revenue, and announced a CFO transition. Byrna Techno
Check-Cap, Outset Medical, Vincerx Pharma Among Healthcare Movers
ACB, XTIA and EDUC Among Mid-day Movers
Envoy Medical Price Target Raised to $6.00/Share From $3.00 by Lake Street
Envoy Medical Price Target Raised to $6.00/Share From $3.00 by Lake Street
Lake Street Maintains Buy on Envoy Medical, Raises Price Target to $6
Lake Street analyst Frank Takkinen maintains Envoy Medical (NASDAQ:COCH) with a Buy and raises the price target from $3 to $6.
Envoy Medical Analyst Ratings
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating 04/03/2024 22.45% Lake Street $3 → $6 Maintains Buy 12/21/2023 — Northland Capital Markets Initiates Cove
Envoy Medical (COCH) Gets a Buy From Lake Street
Envoy Medical Q4 EPS $0.08 Beats $(0.20) Estimate, Sales $95.00K Beat $87.50K Estimate
Envoy Medical (NASDAQ:COCH) reported quarterly earnings of $0.08 per share which beat the analyst consensus estimate of $(0.20) by 140 percent. The company reported quarterly sales of $95.00 thousand
Envoy Medical Reports FY Results
Envoy Medical FY23 EPS $(2.38) Down From $(1.57) YoY, Revenue $316K Up From $237K YoY
As of December 31, 2023 cash and cash equivalents were approximately $4.2 million.
No Data